Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Sep;44(9):e12939.
doi: 10.1111/pim.12939. Epub 2022 Jul 5.

The effect of helminth infection on vaccine responses in humans and animal models: A systematic review and meta-analysis

Affiliations
Meta-Analysis

The effect of helminth infection on vaccine responses in humans and animal models: A systematic review and meta-analysis

Agnes Natukunda et al. Parasite Immunol. 2022 Sep.

Abstract

Vaccination has potential to eliminate infectious diseases. However, parasitic infections such as helminths may hinder vaccines from providing optimal protection. We reviewed existing literature on the effects of helminth infections and their treatment on vaccine responses in humans and animals. We searched literature until 31 January 2022 in Medline, EMBASE, Global health, Scopus, and Web of science; search terms included WHO licensed vaccines and human helminth types. Standardized mean differences (SMD) in vaccine responses between helminth infected and uninfected or anthelminthic treated and untreated individuals were obtained from each study with suitable data for meta-analysis, and combined using a random effects model. Analysis was stratified by whether helminth exposure was direct or prenatal and by vaccine type. This study is registered with PROSPERO (CRD42019123074). Of the 4402 articles identified, 37 were included in the review of human studies and 24 for animal experiments. For human studies, regardless of vaccine type, overall SMD for helminth uninfected/treated, compared to infected/untreated, was 0.56 (95% CI 0.04-1.07 and I2 = 93.5%) for direct helminth exposure and 0.01 (95% CI -0.04 to 0.07 and I2 = 85.9%) for prenatal helminth exposure. Effects of anthelminthic treatment were inconsistent, with no overall benefit shown. Results differed by vaccine type, with responses to live vaccines most affected by helminth exposure. For animal studies, the most affected vaccine was BCG. This result indicates that helminth-associated impairment of vaccine responses is more severe for direct, than for prenatal, helminth exposure. Further research is needed to ascertain whether deworming of individuals before vaccination may help improve responses.

Keywords: helminths; immunity; meta-analysis; systematic review; vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flow diagram of study selection and screening
FIGURE 2
FIGURE 2
Forest plot of the effect of direct helminth infection or anthelminthic treatment on vaccine responses. References and study specific standardized mean differences are presented in Appendix 4 in Supporting Information.
FIGURE 3
FIGURE 3
Forest plot of the effect of prenatal helminth infection or anthelminthic treatment on vaccine responses. References and study specific standardized mean differences are presented in Appendix 5 in Supporting Information.

References

    1. World Health Organization . Immunization coverage [Internet]. 2020. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
    1. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995;346:1339‐1345. - PubMed
    1. Barreto ML, Pilger D, Pereira SM, et al. Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses. Vaccine. 2014;32(30):3759‐3764. doi:10.1016/j.vaccine.2014.05.042 - DOI - PubMed
    1. Muyanja E, Ssemaganda A, Ngauv P, et al. Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. J Clin Invest. 2014;124(7):3147‐3158. - PMC - PubMed
    1. Geneva:World Health Organization . World malaria report 2020: 20 years of global progress and challenges. 2020.

Publication types